CSIMarket Company Name, Ticker, Industry, else..
 
Kalvista Pharmaceuticals Inc   (NASDAQ: KALV)
 

Kalvista Pharmaceuticals Inc's Suppliers Performance

KALV's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
KALV Costs vs Sales of Suppliers Growth

• More on KALV Suppliers






Kalvista Pharmaceuticals Inc's Comment on Supply Chain


The company utilizes third-party manufacturers and collaborators for the production, storage, and distribution of clinical trial and commercial supplies of EKTERLY (sebetralstat) and other product candidates. These third-party manufacturers are required to comply with current Good Manufacturing Practices (cGMP) and FDA regulations. The company does not exercise day-to-day control over these manufacturers but retains responsibility for compliance with applicable laws and regulations. Risks associated with third-party manufacturing include regulatory compliance issues, quality assurance challenges, potential breaches of agreements, misappropriation of proprietary information, and termination of agreements, which may result in regulatory sanctions and delays.

Kalvista Pharmaceuticals Inc's Comment on Supply Chain


The company utilizes third-party manufacturers and collaborators for the production, storage, and distribution of clinical trial and commercial supplies of EKTERLY (sebetralstat) and other product candidates. These third-party manufacturers are required to comply with current Good Manufacturing Practices (cGMP) and FDA regulations. The company does not exercise day-to-day control over these manufacturers but retains responsibility for compliance with applicable laws and regulations. Risks associated with third-party manufacturing include regulatory compliance issues, quality assurance challenges, potential breaches of agreements, misappropriation of proprietary information, and termination of agreements, which may result in regulatory sanctions and delays.







KALV's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Kalvista Pharmaceuticals Inc 1,473.75 12.69 -185.29 45
SUBTOTAL 0.00 0.00 0.00 -


Sources: Kalvista Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Kalvista Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.